Evidence map›Paper›PMID 31104192›Full record

ArticleMedical oncology (Northwood, London, England)2019

Bone marrow examination in patients with Ewing sarcoma/peripheral primitive neuroectodermal tumor without metastasis based on

Chiaki Inagaki, Tatsunori Shimoi, Hitomi Sumiyoshi Okuma, Asuka Kawachi, Kazuki Sudo, Akihiko Shimomura, Emi Noguchi, Makoto Kodaira, Mayu Yunokawa, Kan Yonemori and 6 more

Open access · hybridAbstract read
PubMed Publisher
In one paragraph

Article in Medical oncology (Northwood, London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Chiaki InagakiDepartment of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, 104-0045, Japan.
Tatsunori ShimoiDepartment of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, 104-0045, Japan. tshimoi@ncc.go.jp.
Hitomi Sumiyoshi OkumaDepartment of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, 104-0045, Japan.
Asuka KawachiDepartment of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, 104-0045, Japan.
Kazuki SudoDepartment of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, 104-0045, Japan.
Akihiko ShimomuraDepartment of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, 104-0045, Japan.
Emi NoguchiDepartment of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, 104-0045, Japan.
Makoto KodairaDepartment of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, 104-0045, Japan.
Mayu YunokawaDepartment of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, 104-0045, Japan.
Kan YonemoriDepartment of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, 104-0045, Japan.
Chikako ShimizuDepartment of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, 104-0045, Japan.
Ayumu ArakawaDepartment of Pediatric Oncology, National Cancer Center Hospital, Tokyo, Japan.
Chitose OgawaDepartment of Pediatric Oncology, National Cancer Center Hospital, Tokyo, Japan.
Akihiko YoshidaDepartment of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.
Yasuhiro FujiwaraDepartment of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, 104-0045, Japan.
Kenji TamuraDepartment of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, 104-0045, Japan.
Osaka University · JPTokyo National Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ewing sarcoma/peripheral primitive neuroectodermal tumor (ES/PNET) is an aggressive bone tumor. Bone marrow aspiration and biopsy (BMAB) has been recognized as the gold standard for assessing bone marrow status. While the latest guideline suggests the need to omit bone marrow aspiration in patients with no findings on

Indexed as

AdolescentAdultBiopsy, NeedleBone MarrowBone NeoplasmsChildFemaleFluorodeoxyglucose F18HumansMaleMiddle AgedNeuroectodermal Tumors, Primitive, PeripheralPositron Emission Tomography Computed TomographyRadiopharmaceuticalsRetrospective StudiesSarcoma, EwingFluorodeoxyglucose F18Radiopharmaceuticals18F-FDG PET/CTBone marrow involvementEwing sarcoma/peripheral primitive neuroectodermal tumors

Identifiers

PMID31104192
OpenAlexW2945032013

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.